ABIGAIL MAIN: Open Payments
NPI 1982285003 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,002 in 109 payments from 19 companies in 2025. Trend: 2023 $1,487 · 2024 $1,863 · 2025 $3,002
Food & beverage: $1,872Consulting: $1,125Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $1,324 |
| ABBVIE INC. | 38 | $542 |
| Arcutis Biotherapeutics, Inc. | 12 | $190 |
| Regeneron Healthcare Solutions, Inc. | 9 | $176 |
| PFIZER INC. | 9 | $153 |
| Novartis Pharmaceuticals Corporation | 8 | $136 |
| Galderma Laboratories, L.P. | 6 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Incyte Corporation | 2 | $49 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
Products named: TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, Zoryve, CIBINQO, COSENTYX, Sotyktu.
Industry payments across IN — which companies pay providers there.
